Company / FCF Margin
LEXICON PHARMACEUTICALS, INC. FCF Margin History
FY2013-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-13485.6%
FY2025
5-year range
-64875.5% / -221.9%
FY2021-FY2025
Trend
+79.2%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin returned to growth in FY2025 after 4 years of decline, reaching -13485.6%.
Based on SEC 10-K filings.
-13485.6% in FY2025 with a 10-year CAGR of -9309.2%.
Improved from -29610.1% to -13485.6% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -9309.2pp
Key checks
Key Insights
- In FY2025, fcf margin increased 79.2% year-over-year.
- Peak fcf margin was recorded in FY2017.
- Lowest fcf margin in the period was in FY2024.
Company context
Key Data Points
- Altman Z-Score -1.98 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -13485.6% | +79.2% |
| FY2024 | -64875.5% | -119.1% |
| FY2023 | -29610.1% | -4866.5% |
| FY2019 | -596.2% | -168.7% |
| FY2018 | -221.9% | -256.9% |
| FY2017 | 141.4% | +142.7% |
| FY2016 | -331.2% | +92.1% |
| FY2015 | -4176.4% | +52.1% |
| FY2014 | -8719.2% | -80.9% |
| FY2013 | -4821.2% | -183.4% |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026